Byron Kieser | Authors

Byron Kieser is Director, Small Molecule Marketing at Applied Biosystems/MDS SCIEX, and is based in Toronto, Ontario, Canada.


Mass Spectrometry Advances Translational Medicine Trends in Proteomic and Small-Molecule Applications

Enabling targeted quantitative proteomics applications and hypothesis-driven inquiries will help researchers to understand how proteins function in living systems. The discovery and validation of small molecule and protein-based biomarkers, and the eventual translation of these discoveries from the research lab to the clinic, involves robust mass spectrometry (MS) systems and software that make it easier for technicians to perform routine sample analyses on liquid chromatography (LC)–MS-MS systems, which continue to be used in an increasing number of both protein and small molecule analysis applications.